Postepy biochemii · 2025
[Hyperbaric oxygen therapy (HBOT) in the treatment of autism spectrum disorders].
СтатьяОбзорАннотация на английскомНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jankowska Karolina, Świderski Nikodem, Wójtowicz Weronika, Iwan Magdalena, Bielecka-Wajdman Anna
Аннотация
Autism spectrum disorder (ASD) is a heterogeneous group of neurodevelopmental disorders whose etiology involves complex interactions of environmental, genetic, and neurobiological factors. The developing knowledge regarding the genesis of this disorder, along with the increasing number of diagnosed cases, creates a need to search for more effective treatment methods. One potential complementary therapy is hyperbaric oxygen therapy (HBOT). Its potential mechanism of action in ASD is primarily associated with its anti-inflammatory effects, modulation of neuroplasticity, and a potential impact on oxidative stress levels. Current research shows that HBOT may improve certain behavioral and cognitive factors in individuals with ASD, such as speech, communication, and psychosocial functioning. However, these results are often inconsistent due to potential adverse effects of HBOT, such as barotrauma and oxygen toxicity. This article highlights the significance of HBOT in ASD based on available literature from experimental studies conducted between 2012 and 2025.